Paper36738564
Chemical language models for de novo drug design: Challenges and opportunities.
Grisoni F. Curr Opin Struct Biol, 2023. Cited by 82 papers, by iCite.
Cite this record
ConductScience Library. Chemical language models for de novo drug design: Challenges and opportunities. Papers, record 36738564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36738564
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Design | Major topic |
| Drug Discovery | Major topic |
| Models, Chemical |
Source PubMed
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42814605 | MMP2Mol: a matched molecular pairs-based framework for ligand-based de novo drug design. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42814605 | PubMed |
| 42780543 | Artificial intelligence-driven drug discovery: a deep learning paradigm shift in pharmaceutical research and development. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42780543 | PubMed |
| 42567977 | Artificial intelligence in drug discovery - what it is, where we stand and the path forward. | Nat Rev Drug Discov | 2026 | https://conductscience.org/library/papers/42567977 | PubMed |
| 42563013 | Why do AI projects fail in drug development and pharma? Insights from multi-year Pistoia Alliance studies. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42563013 | PubMed |
| 42552350 | Diversity Beats Size Scaling for Chemical Language Models. | NPJ Drug Discov | 2026 | https://conductscience.org/library/papers/42552350 | PubMed |
| 42547887 | Transformers for molecular property prediction: domain adaptation efficiently improves performance. | J Cheminform | 2026 | https://conductscience.org/library/papers/42547887 | PubMed |
| 42519174 | ColdstartMHDTI: integrating biomolecular pretraining and attention-based heterogeneous graph learning for drug-target interaction prediction. | Front Chem | 2026 | https://conductscience.org/library/papers/42519174 | PubMed |
| 42450185 | Evaluating AI-Generated Molecules for Drug Discovery: From Generic Metrics to Translational Readiness. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450185 | PubMed |
| 42380605 | Quantum-machine-assisted drug discovery. | NPJ Drug Discov | 2026 | https://conductscience.org/library/papers/42380605 | PubMed |
| 42258020 | A round-robin exercise for the precise prediction of aqueous solubility of organic chemicals using chemometric, machine learning, and stacking ensemble of deep learning models. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42258020 | PubMed |
| 42211383 | Data-driven design and screening of novel Klebsiella pneumoniae carbapenemase-2 β-lactamase inhibitors using a generative CLM. | RSC Adv | 2026 | https://conductscience.org/library/papers/42211383 | PubMed |
| 42115404 | SmileyLlama: modifying large language models for directed chemical space exploration. | Nat Comput Sci | 2026 | https://conductscience.org/library/papers/42115404 | PubMed |
| 42112265 | Apo2Mol: 3D Molecule Generation via Dynamic Pocket-Aware Diffusion Models. | Proc AAAI Conf Artif Intell | 2026 | https://conductscience.org/library/papers/42112265 | PubMed |
| 42083036 | Framework for evaluating explainable AI in antimicrobial drug discovery. | J Cheminform | 2026 | https://conductscience.org/library/papers/42083036 | PubMed |
| 42006255 | Fine-Tuning a Transformer Model for METTL3 Lead Optimization. | ACS Bio Med Chem Au | 2026 | https://conductscience.org/library/papers/42006255 | PubMed |
| 41965890 | Structural optimization of drug molecules with incrementally trained language models. | Nat Commun | 2026 | https://conductscience.org/library/papers/41965890 | PubMed |
| 41546836 | A large language model-guided reinforcement learning framework for EGFR anticancer drug design. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/41546836 | PubMed |
| 41531766 | Explainable artificial intelligence for molecular design in pharmaceutical research. | Chem Sci | 2026 | https://conductscience.org/library/papers/41531766 | PubMed |
| 41441186 | AgentMol: Multi-Model AI System for Automatic Drug-Target Identification and Molecule Development. | Methods Protoc | 2025 | https://conductscience.org/library/papers/41441186 | PubMed |
| 41366732 | Application and Prospects of Large Language Models in Small-Molecule Drug Discovery. | Anal Chem | 2025 | https://conductscience.org/library/papers/41366732 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36738564
GET https://conductscience.org/api/papers/v1/36738564/cited_by?page=2